MAIA Biotechnology, Inc.·4

Dec 1, 6:20 AM ET

Vitoc Vlad 4

4 · MAIA Biotechnology, Inc. · Filed Dec 1, 2025

Insider Transaction Report

Form 4
Period: 2025-11-26
Vitoc Vlad
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2025-11-28$1.14/sh+50,000$56,830881,421 total
  • Purchase

    Common Stock

    2025-11-26$1.05/sh+22,000$23,019853,421 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    210,000
Footnotes (3)
  • [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F2]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F3]These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT